Product Description
Anti-ERBB2 (trastuzumab) -AcLysGly-MMAD ADC | ADC-W-633 | Creative Biolabs
Short Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a AcLysGly linker to MMAD
Status: In stock
Expected Delivery Time: 9-11Weeks